Home › Funds › Farallon Capital Management › VCYT
Farallon Capital Management position in VCYT
VERACYTE INC · Health Care
Latest position (Q1 2026)7.00K sh
Reported value held$225.47K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 185.22K | $8.60M | New |
| Q4 2021 | 191.16K | $7.88M | Add |
| Q1 2022 | 32.50K | $896.00K | Reduce |
| Q3 2025 | 7.00K | $240.31K | New |
| Q4 2025 | 7.00K | $294.70K | Hold |
| Q1 2026 | 7.00K | $225.47K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding VCYT
- BlackRock Inc 13.49M sh · $792.06M · Q2 2026
- Fidelity Management & Research (FMR) 7.70M sh · $452.38M · Q2 2026
- Vanguard Group 8.50M sh · $358.02M · Q4 2025
- ARK Invest 2.30M sh · $134.84M · Q2 2026
- Wellington Management Group 2.27M sh · $133.56M · Q2 2026
- Geode Capital Management 2.10M sh · $123.59M · Q2 2026
- Goldman Sachs Group 1.64M sh · $96.49M · Q2 2026
- Morgan Stanley 1.19M sh · $69.99M · Q2 2026
- Bank of America Corp 1.10M sh · $64.74M · Q2 2026
- Northern Trust Corp 996.15K sh · $58.50M · Q2 2026
- Charles Schwab Investment Management 939.98K sh · $55.21M · Q2 2026
- Legal & General Investment Management America 858.14K sh · $50.40M · Q2 2026